Bladder Cancer | Q&A
Armine Smith, M.D., is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an assistant clinical professor of urology at Johns Hopkins University School of Medicine. Dr. Smith is board certified in urology by the American Board of Urology.
Dr. Smith has an expertise in advanced urologic surgery, including open and minimally invasive approaches to oncologic diseases and the latest robotic technologies. She has been selected as a Washington, DC top urologist.
She specializes in many urologic malignancies, including bladder cancer, kidney cancer, penile cancer and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery.
Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer.
Dr. Smith previously served as a clinical instructor in surgery at Lerner College of Medicine and currently works as an assistant clinical professor of urology at George Washington University School of Medicine. She is also a clinical associate of the National Cancer Institute/Urologic Oncology Branch, and is working to earn her Master of Business Administration degree from Johns Hopkins University Carey Business School.
Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association.
Dr. Smith has earned the Cleveland Clinic Innovator Award and the Cleveland Clinic Housestaff Association Award, in addition to the John Quale Fellowship Travel Award and grants from the Greenberg Bladder Cancer Institute, the Cleveland Clinic Research Program Committee and the Flight Attendant Medical Research Institute. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidating risk factors for development of bladder cancer and overcoming resistance to conventional therapy regimens, including development of personalized targeted therapies.
She is a member of Greenberg Bladder Cancer Institute and a co-director of Women's Bladder Cancer Program at Sibley Memorial Hospital.